MAPK3 and chronic obstructive pulmonary disease: Although these results suggest that ERK1/2 signaling is a major stimulator of several COPD-specific pathologies, and its inhibition may present a therapeutic target, inhibiting ERK1/2 signaling will affect many other physiological processes needed to maintain tissue and organ regeneration [59].